Tower Research Capital LLC (Trc) Regulus Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.13 - $2.88 $3,610 - $9,201	3,195 Added 18794.12%	3,212 $9,000
Q4 2023 Feb 13, 2024	SELL	$1.21 - $1.44 $4,318 - $5,139	-3,569 Reduced 99.53%	17 $0
Q3 2023 Nov 14, 2023	SELL	$1.27 - $1.76 $5,388 - $7,467	-4,243 Reduced 54.2%	3,586 $4,000
Q2 2023 Aug 14, 2023	SELL	$0.87 - $1.75 $3,481 - $7,003	-4,002 Reduced 33.83%	7,829 $11,000
Q1 2023 May 09, 2023	BUY	$0.79 - $1.61 $3,814 - $7,774	4,829 Added 68.97%	11,831 $10,000
Q4 2022 Feb 10, 2023	BUY	$1.17 - $1.85 $7,792 - $12,321	6,660 Added 1947.37%	7,002 $10,000
Q3 2022 Nov 10, 2022	SELL	$1.35 - $2.39 $2,627 - $4,650	-1,946 Reduced 85.05%	342 $0
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.4 $3,660 - $7,779	2,288 New	2,288 $5,000

52.6M

155K

34.2K

Ticker RGLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,634,400
Market Cap $23.6M
Description
Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-thre...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.